Celsense posts new whitepaper providing guidance to IND sponsors
Celsense posts new whitepaper providing guidance to IND sponsors
read morePress Release – Study advancing the use of 19F tracer agent in clinical immuno-oncology applications is published in Contrast Media & Molecular Imaging
Study advancing the use of 19F tracer agent in clinical immuno-oncology applications is published in Contrast Media & Molecular Imaging
Press Release – The US National Cancer Institute Awards 5-year Grant to Fund Clinical Trial Using Cell Sense Technology in Patients with Head and Neck Cancers
US National Cancer Institute Awards 5-year Grant
Press Release – Celsense, Inc. to Give Presentation at the International Society for Cell Therapy
Celsense, Inc. to Give Presentation at the International Society for Cell Therapy 2017 Annual Meeting
Continue Exploring
Products
Papers
Real-Time Results,<br />Faster and More Accurate
Celsense offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The mission of the company is to be the standard for cellular imaging in human health.
GET IN TOUCH
Send Us A Message
© 2018 Celsense, Inc. All rights reserved.